← Open Payments lookup

MELISSA DOUBERLY: Open Payments

NPI 1942611744 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,487 in 54 payments from 15 companies in 2025. Trend: 2023 $899 · 2024 $1,331 · 2025 $1,487

Food & beverage: $1,403Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.14$543
ABBVIE INC.16$335
Madrigal Pharmaceuticals6$194
GENZYME CORPORATION4$119
Takeda Pharmaceuticals U.S.A., Inc.2$44
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$44
Ardelyx, Inc.2$37
QOL Medical, LLC1$35
Regeneron Healthcare Solutions, Inc.1$26
Novo Nordisk Inc1$23

Products named: TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, LINZESS, SKYRIZI, XIFAXAN, IBSRELA.

Industry payments across FL — which companies pay providers there.